Tudor Investment Corp’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,955
Closed -$43K 1358
2018
Q4
$43K Hold
5,955
﹤0.01% 961
2018
Q3
$114K Buy
5,955
+2,873
+93% +$103K ﹤0.01% 1017
2018
Q2
$174K Buy
3,082
+1,532
+99% +$77.7K 0.01% 951
2018
Q1
$66K Buy
+1,550
New +$66.6K ﹤0.01% 941
2016
Q3
Sell
-2,657
Closed -$331K 1854
2016
Q2
$331K Buy
2,657
+585
+28% +$67.3K 0.01% 1107
2016
Q1
$173K Buy
+2,072
New +$171K ﹤0.01% 1535
2015
Q4
Sell
-2,034
Closed -$249K 1933
2015
Q3
$249K Buy
+2,034
New +$276K 0.01% 1219
2014
Q2
Sell
-1,756
Closed -$226K 1418
2014
Q1
$226K Buy
+1,756
New +$273K 0.01% 988

Other funds holding ELGX

Tudor Investment Corp's ELGX Position: Q1 2019 in Review

Tudor Investment Corp sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 5,955 shares — an estimated $43K sold.

Tudor Investment Corp first reported a position in ELGX in Q1 2014 and held it in 8 quarters. The position peaked at $331K in Q2 2016. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Tudor Investment Corp reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Tudor Investment Corp sold 5,955 Endologix Inc shares in Q1 2019, an estimated $43K.
  • Tudor Investment Corp first reported a position in Endologix Inc in Q1 2014 and held it in 8 quarters.
  • Tudor Investment Corp's Endologix Inc position peaked at $331K in Q2 2016.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Tudor Investment Corp's 13F filing for Q1 2019, filed 15 May 2019.